MDT Insider Trading
Medtronic plc | Electromedical & Electrotherapeutic Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Medtronic plc provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Electromedical & Electrotherapeutic Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-04 00:25 | 2019-12-02 | WHITE ROBERT JOHN | Officer - EVP & President MITG | OPT+S | $110.62 | 52,166 | $5,770,827 | 52,068 | 0.0% |
| 2019-11-19 01:31 | 2019-11-15 | COYLE MICHAEL J | Officer - EVP & Group Pres, Cardiac&Vasc | OPT+S | $111.25 | 36,874 | $4,102,092 | 188,262 | 0.0% |
| 2019-11-16 01:49 | 2019-11-14 | COYLE MICHAEL J | Officer - EVP & Group Pres, Cardiac&Vasc | OPT+S | $109.77 | 2,102 | $230,731 | 188,262 | 0.0% |
| 2019-11-05 02:28 | 2019-11-01 | WHITE ROBERT JOHN | Officer - EVP & President MITG | OPT+S | $109.33 | 52,165 | $5,702,996 | 52,068 | 0.0% |
| 2019-11-05 02:26 | 2019-11-01 | COYLE MICHAEL J | Officer - EVP & Group Pres, Cardiac&Vasc | OPT+S | $109.50 | 38,976 | $4,267,872 | 188,262 | 0.0% |
| 2019-10-01 00:52 | 2019-09-27 | Kuntz Richard | Officer - SVP & Chief Medical & Science | SELL | $107.51 | 21,425 | $2,303,494 | 78,816 | -21.4% |
| 2019-09-13 00:55 | 2019-09-10 | HAKAMI HOOMAN | Officer - EVP & Group President Diabetes | OPT+S | $107.31 | 82,877 | $8,893,713 | 30,761 | 0.0% |
| 2019-08-07 00:53 | 2019-08-05 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | SELL | $100.31 | 4,000 | $401,240 | 52,906 | -7.0% |
| 2019-08-03 01:32 | 2019-08-02 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | SELL | $102.02 | 6,599 | $673,230 | 56,906 | -10.4% |
| 2019-08-03 01:29 | 2019-08-02 | Kuntz Richard | Officer - SVP & Chief Medical & Science | SELL | $102.02 | 5,719 | $583,452 | 100,241 | -5.4% |
| 2019-07-24 01:03 | 2019-07-22 | Kuntz Richard | Officer - SVP & Chief Medical & Science | SELL | $101.12 | 3,438 | $347,651 | 100,127 | -3.3% |
| 2019-06-19 00:31 | 2019-06-17 | Surface Carol A | Officer - SVP, Chief HR Officer | SELL | $97.66 | 9,000 | $878,976 | 34,158 | -20.9% |
| 2019-06-14 23:51 | 2019-06-12 | HAKAMI HOOMAN | Officer - EVP & Group President Diabetes | OPT+S | $97.49 | 52,664 | $5,134,213 | 42,673 | 0.0% |
| 2019-06-08 00:34 | 2019-06-06 | Martha Geoffrey | Officer - EVP & GroupPres Restora Therap | SELL | $96.05 | 11,000 | $1,056,583 | 48,918 | -18.4% |
| 2019-05-30 00:37 | 2019-05-28 | TEN HOEDT ROB | Officer - EVP & President EMEA | SELL | $91.88 | 9,000 | $826,920 | 58,785 | -13.3% |
| 2019-05-29 02:54 | 2019-05-24 | ANDERSON RICHARD H | Director | BUY | $92.40 | 10,900 | $1,007,160 | 89,912 | +13.8% |
| 2019-01-09 20:28 | 2019-01-09 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | BUY | $83.87 | 3,000 | $251,610 | 83,680 | +3.7% |
| 2019-01-09 20:27 | 2019-01-09 | ISHRAK OMAR | Director, Officer - Chairman & CEO | BUY | $84.05 | 12,000 | $1,008,540 | 570,722 | +2.1% |
| 2018-09-25 23:27 | 2018-09-24 | Martha Geoffrey | Officer - EVP & GroupPres Restora Therap | OPT+S | $97.93 | 49,799 | $4,876,667 | 59,202 | 0.0% |
| 2018-09-05 23:33 | 2018-08-31 | HAKAMI HOOMAN | Officer - EVP & Group President Diabetes | OPT+S | $96.29 | 26,159 | $2,518,798 | 62,647 | 0.0% |
| 2018-08-29 23:38 | 2018-08-28 | Kuntz Richard | Officer - SVP & Chief Medical & Science | OPT+S | $95.88 | 47,176 | $4,523,089 | 105,403 | 0.0% |
| 2018-08-24 23:32 | 2018-08-23 | POZEN ROBERT C | Director | OPT+S | $95.94 | 3,218 | $308,738 | 60,964 | 0.0% |
| 2018-08-23 23:36 | 2018-08-22 | COYLE MICHAEL J | Officer - EVP & Group Pres, Cardiac&Vasc | OPT+S | $95.50 | 145,544 | $13,899,161 | 200,180 | 0.0% |
| 2018-08-24 00:03 | 2018-08-23 | ANDERSON RICHARD H | Director | BUY | $95.88 | 2,600 | $249,285 | 76,920 | +3.5% |
| 2018-06-12 23:35 | 2018-06-11 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | SELL | $86.82 | 8,910 | $773,566 | 51,842 | -14.7% |
| 2018-06-11 23:36 | 2018-06-08 | Kuntz Richard | Officer - SVP & Chief Medical & Science | SELL | $87.13 | 11,500 | $1,001,995 | 105,923 | -9.8% |
| 2018-03-15 00:27 | 2018-03-13 | Lenehan James T | Director | OPT+S | $83.56 | 1,306 | $109,123 | 47,028 | 0.0% |
| 2018-03-07 00:09 | 2018-03-02 | Surface Carol A | Officer - SVP, Chief HR Officer | OPT+S | $78.18 | 24,479 | $1,913,854 | 29,531 | 0.0% |
| 2018-01-11 01:40 | 2018-01-09 | Kuntz Richard | Officer - SrVP & Chief Scien, Clin, Reg | OPT+S | $86.21 | 78,526 | $6,769,726 | 117,107 | 0.0% |
| 2018-01-09 01:07 | 2018-01-05 | HAKAMI HOOMAN | Officer - EVP & Group President Diabetes | OPT+S | $85.00 | 26,158 | $2,223,430 | 65,828 | 0.0% |
| 2017-12-19 01:40 | 2017-12-15 | Hanson Bryan C | Officer - EVP, President, MITG | SELL | $82.82 | 16,000 | $1,325,120 | 88,818 | -15.3% |
| 2017-11-18 01:25 | 2017-11-16 | Hanson Bryan C | Officer - EVP, President, MITG | SELL | $79.02 | 16,000 | $1,264,320 | 109,067 | -12.8% |
| 2017-10-17 00:21 | 2017-10-16 | Hanson Bryan C | Officer - EVP, President, MITG | SELL | $78.03 | 16,000 | $1,248,480 | 124,555 | -11.4% |
| 2017-09-19 02:11 | 2017-09-15 | ISHRAK OMAR | Director, Officer - Chairman & CEO | OPT+S | $81.63 | 140,407 | $11,461,423 | 528,096 | 0.0% |
| 2017-07-18 23:28 | 2017-07-17 | Hanson Bryan C | Officer - EVP, President, MITG | SELL | $88.57 | 12,000 | $1,062,840 | 136,912 | -8.1% |
| 2017-06-22 00:14 | 2017-06-21 | ANDERSON RICHARD H | Director | BUY | $88.90 | 5,600 | $497,840 | 71,910 | +8.4% |
| 2017-03-22 01:07 | 2017-03-20 | TEN HOEDT ROB | Officer - EVP & President EMEA | OPT+S | $81.58 | 50,757 | $4,140,594 | 51,238 | 0.0% |
| 2017-03-17 22:23 | 2017-03-15 | ISHRAK OMAR | Director, Officer - Chairman & CEO | OPT+S | $82.82 | 95,000 | $7,868,014 | 550,616 | 0.0% |
| 2017-03-06 21:57 | 2017-03-02 | HAKAMI HOOMAN | Officer - EVP & Group President Diabetes | OPT+S | $82.33 | 52,316 | $4,307,019 | 58,929 | 0.0% |
| 2016-12-14 23:57 | 2016-12-13 | POZEN ROBERT C | Director | BUY | $73.21 | 13,660 | $999,983 | 67,223 | +25.5% |
| 2016-11-23 20:32 | 2016-11-23 | Lenehan James T | Director | BUY | $73.27 | 2,000 | $146,533 | 40,252 | +5.2% |
| 2016-09-28 23:25 | 2016-09-26 | Kuntz Richard | Officer - SrVP & Chief Scien, Clin, Reg | OPT+S | $86.68 | 42,340 | $3,670,052 | 107,085 | 0.0% |
| 2016-09-19 23:45 | 2016-09-15 | ISHRAK OMAR | Director, Officer - Chairman & CEO | SELL | $84.93 | 61,925 | $5,259,414 | 565,916 | -9.9% |
| 2016-09-20 00:06 | 2016-09-15 | Powell Kendall J | Director | OPT+S | $85.45 | 7,907 | $675,614 | 26,375 | 0.0% |
| 2016-08-31 22:24 | 2016-08-29 | Hanson Bryan C | Officer - EVP, President, MITG | OPT+S | $87.00 | 15,000 | $1,305,000 | 153,192 | 0.0% |
| 2016-07-27 22:19 | 2016-07-26 | Hanson Bryan C | Officer - EVP, President, MITG | OPT+S | $87.00 | 15,000 | $1,305,000 | 93,717 | 0.0% |
| 2016-07-19 20:57 | 2016-07-15 | Martha Geoffrey | Officer - EVP & GroupPres Restora Therap | SELL | $88.26 | 3,766 | $332,402 | 26,273 | -12.5% |
| 2016-07-14 23:40 | 2016-07-13 | Ellis Gary Lee | Officer - EVP & Global Ops and IT | OPT+S | $88.64 | 35,495 | $3,146,206 | 180,939 | 0.0% |
| 2016-07-14 23:28 | 2016-07-13 | JACKSON SHIRLEY A | Director | OPT+S | $88.64 | 2,104 | $186,498 | 33,989 | 0.0% |
| 2016-07-08 16:22 | 2016-07-06 | Surface Carol A | Officer - SVP, Chief HR Officer | SELL | $87.08 | 9,787 | $852,273 | 59,784 | -14.1% |
How to Interpret $MDT Trades
Not every insider transaction in Medtronic plc is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MDT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for MDT
Insider activity data for Medtronic plc is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MDT, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.